Ki67 and salivary cancer

Cancer Investigation

Volumn 26, Issue 10, 2008, Pages 1015-1023

  Ben Izhak, Ofer ^a   Akrish, Sharon ^a   Nagler, Rafael M ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cancer; Ki67; Malignancies; Prognosis; Salivary glands

Indexed keywords

HEPARANASE; KI 67 ANTIGEN; PROTEIN P27; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CANCER; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROBABILITY; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 57749187643     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802088968     Document Type: Article

References (23)

1. Hofmann, K.; Bucher, P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem Sci 1995, 20, 347-349.
2. Schluter, C.; Duchrow, M.; Wohlenberg, C.; Becker, M.H.; Key, G.; Flad, H.D.; Gerdes, J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993, 123, 513-522.
3. Plaat, B.; Kole, A.; Mastik, M.; Hoekstra, H.; Molenaar, W.; Vaalburg, W. Protein synthesis rate measured with L-[1-11C]tyrosine positron emission tomography correlates with mitotic activity and MIB-1 antibody-detected proliferation in human soft tissue sarcomas. Eur J Nucl Med 1999, 26, 328-332.
4. Pich, A.; Chiusa, L.; Navone, R. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 2004, 15, 1319-1329.
5. Brown, D.C.; Gatter, K.C. Ki67 protein: the immaculate deception? Histopathol 2002, 40, 2-11.
6. van Diest, P.J.; van der Wall, E.; Baak, J.P. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 2004, 57, 675-681.
7. Spiro, R.H.; Dubner, S. Salivary gland tumors. Curr Opin Oncol 1990, 2, 589-595.
8. Eneroth, C.M. Salivary gland tumors in the parotid gland, submandibular gland and the palate region. Cancer 1971, 27, 1415-1418.
9. Eveson, J.W.; Cawson, R.A. Salivary gland tumors. a review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 1985, 146, 51-58.
10. Nagler, R.M.; Barak, M.; Ben-Aryeh, H.; Peled, M.; Filatov, M.; Laufer, D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 1999, 35, 1018-1025.
11. Handra-Luca, A.; Ruhin, B.; Lesty, C.; Fouret, P. P27, Skp2, and extra-cellular signal-related kinase signaling in human salivary gland mucoepidermoid carcinoma. Oral Oncol 2006, 42, 1005-1100.
12. Katori, H.; Nozawa, A.; Tsukuda, M. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma. Auris Nasus Larynx 2007, 34, 79-84.
13. Katori, H.; Nozawa, A.; Tsukuda, M. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma. Acta Otolaryngol 2007, 127, 1207-1213.
14. Matsubayashi, S.; Yoshihara, T. Carcinoma ex pleomorphic adenoma of the salivary gland: An immunohistochemical study. Eur Arch Otorhinolaryngol 2007, 264, 789-95.
15. Ben-Izhak, O.; Laster, Z.; Araidy, S.; Nagler, R.M. TUNEL - an efficient predictor of salivary malignancies. Br J Cancer 2007, 96, 1101-1106.
16. Ben Izhak, O.; Kaplan-Cohen, V.; Ilan, N.; Gan, S.; Vlodavsky, I.; Nagler, R. Heparanase expression in malignant salivary gland tumors inversely correlates with long-term survival. Neoplasia 2006, 8, 879-884.
17. Nagler, R.; Kerner, H.; Laufer, D.; Ben-Eliezer, S.; Minkov, I.; Ben-Yizhak, O. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study. Cancer Lett 2002, 2, 137-150.
18. Ben-Izhak, O.; Kablan, F.; Laster, Z.; Nagler, R.M. Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert - first report. Oral Oncol 2005, 41, 851-860.
19. Hershko, D.D.; Shapira, M. Prognostic role of p27 Kip1 deregulation in colorectal cancer. Cancer 2006, 107, 668-675.
20. Kudo, Y.; Kitajima, S.; Ogawa, I.; Miyauchi, M.; Takata, T. Downregulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol 2005, 41, 105-116.
21. Bloom, J.; Pagano, M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 2003, 13, 41-47.
22. Nakayama, K.I.; Hatakeyama, S.; Nakayama, K. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27 Kip1. Biochem Biophys Res Commun 2001, 282, 853-860.
23. Strianese, D.; Baldi, G.; Staibano, S.; Baldi, A.; De Rosa, G.; Tranfa F, Bonavolonta, G. Expression of apoptosis-related markers in malignant epithelial tumors of the lacrimal gland and their relation to clinical outcome. Br J Ophthalmol 2007, 91, 1239-1243.